GLPG
Galapagos NV ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.86B
P/E Ratio
3.18
EPS
$8.71
Beta
0.12
52W High
$37.78
52W Low
$24.74
50-Day MA
$30.14
200-Day MA
$32.11
Dividend Yield
—
Profit Margin
46.80%
Forward P/E
303.03
PEG Ratio
0.00
About Galapagos NV ADR
Galapagos NV, a clinical-stage biotechnology company, discovers, develops and markets several small molecule drugs. The company is headquartered in Mechelen, Belgium.
Fundamentals
| Revenue (TTM) | $1.04B |
| Gross Profit (TTM) | $563.52M |
| EBITDA | $662.96M |
| Operating Margin | -983.00% |
| Return on Equity | 16.30% |
| Return on Assets | 10.70% |
| Revenue/Share (TTM) | $0.79 |
| Book Value | $2.90 |
| Price-to-Book | 0.50 |
| Price-to-Sales (TTM) | 1.78 |
| EV/Revenue | 1.184 |
| EV/EBITDA | -31.50 |
| Quarterly Earnings Growth (YoY) | 3036.00% |
| Quarterly Revenue Growth (YoY) | -91.40% |
| Shares Outstanding | $65.90M |
| Float | $44.52M |
| % Insiders | 25.35% |
| % Institutions | 22.31% |
Historical Volatility
HV 10-Day
25.37%
HV 20-Day
21.37%
HV 30-Day
24.74%
HV 60-Day
28.68%
HV Rank
27.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($28.09 target)
3
HoldMore HEALTHCARE Stocks
Data last updated: 5/9/2026